Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Parabilis Medicines' million-dollar help to upgrade the Cancer Drug space
Date 13 January 2026

Parabilis Medicines' million-dollar help to upgrade the Cancer Drug space

Introduction Parabilis Medicines, formerly FogPharma, is a well-established clinical-level biopharma company passionate about developing effective peptide therapeutics known as Helicons. Helicon is l...

ABS's buyout of Cureline's excellence to bolster biopharma drug discovery
Date 12 January 2026

ABS's buyout of Cureline's excellence to bolster biopharma drug discovery

Introduction ABS Bio, since its establishment in 1990, has delivered the best-in-class critical scientific relevant services involving tissue processing, cell culture, human biospecimens, biostorage ...

Crinetics bets a million relying on its new Phase 2 results
Date 12 January 2026

Crinetics bets a million relying on its new Phase 2 results

Introduction Crinetics Pharmaceuticals is popular for discovering new medicines for curing endocrine-based diseases. The company came into force in 2008 with its regional origin in San Diego, Califor...

Novoron secured funding from NIH/NIA SBIR for its Alzheimer's Drug Discovery
Date 09 January 2026

Novoron secured funding from NIH/NIA SBIR for its Alzheimer's Drug Discovery

Announcement Novoron Bioscience, a well-known biotechnology company in San Diego since 2014, has been establishing new therapies for neurological injury and neurodegenerative diseases, and has now ea...

Intelligent and Syrma entered a manufacturing partnership agreement
Date 06 January 2026

Intelligent and Syrma entered a manufacturing partnership agreement

Announcement Intelligent Bio Solutions Inc., a leading medical technology company serving an emerging, non-invasive brilliant testing solutions, have inked a manufacturing deal with Syrma Johari MedT...

Johnson & Johnson obtained Halda's robust platform to equip its potential in business operations
Date 01 January 2026

Johnson & Johnson obtained Halda's robust platform to equip its potential in business operations

Announcement Johnson & Johnson, the popular company, has completed its acquisition of Halda Therapeutics OpCo, Inc., a known clinical-level biotechnology company. Along with this acquisition, Joh...

Coforge acquired Encora's excellence to speed up AI in hi-tech and healthcare verticals
Date 31 December 2025

Coforge acquired Encora's excellence to speed up AI in hi-tech and healthcare verticals

Announcement Coforge Limited, a popular entity known as NIIT Technologies Limited, announced its acquisition of Encora. Encora is a California-based technology services company specialising in elevat...

Morgan Stanley fixed its concentration on Healthcare Tech and GoodRx (GDRX)
Date 31 December 2025

Morgan Stanley fixed its concentration on Healthcare Tech and GoodRx (GDRX)

Announcement Morgan Stanley has cut its firm’s price to $4 from $5 for GoodRx (GDRX). GoodRx Holdings Inc. is one of the most affordable penny stocks to invest in. Morgan has maintained a consi...

JCR and Italfarmaco inked a multipurpose smart deal
Date 30 December 2025

JCR and Italfarmaco inked a multipurpose smart deal

Announcement Italfarmaco S.p.A and JCR Pharmaceuticals Co., Ltd. excitedly announced their exclusive licensing agreement for the marketing and development of givinostat in Japan. Alongside, both comp...

Samsung engaged in a definitive agreement to fully obtain HGS from GSK
Date 26 December 2025

Samsung engaged in a definitive agreement to fully obtain HGS from GSK

Announcement Samsung Biologics, a popular contract development and manufacturing organisation (CDMO), has declared that Samsung Biologics America, a fully owned U.S subsidiary, has signed a definitiv...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.